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Abstract
We establish the inferential properties of the mean-difference estimator for the average treatment
effect in randomized experiments where each unit in a population is randomized to one of two
treatments and then units within treatment groups are randomly sampled. The properties of this
estimator are well-understood in the experimental design scenario where first units are randomly
sampled and then treatment is randomly assigned, but not for the aforementioned scenario
where the sampling and treatment assignment stages are reversed. We find that the inferential
properties of the mean-difference estimator under this experimental design scenario are identical
to those under the more common sample-first-randomize-second design. This finding will bring
some clarifications about sampling-based randomized designs for causal inference, particularly
for settings where there is a finite super-population. Finally, we explore to what extent pre-
treatment measurements can be used to improve upon the mean-difference estimator for this
randomize-first-sample-second design. Unfortunately, we find that pre-treatment measurements
are often unhelpful in improving the precision of average treatment effect estimators under this
design, unless a large number of pre-treatment measurements that are highly associative with
the post-treatment measurements can be obtained. We confirm these results using a simulation
study based on a real experiment in nanomaterials.
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1. Introduction: The Potential Outcomes Framework for Randomized Experi-
ments
In most two-armed randomized experiments conducted to compare the causal effects of two treat-
ments (or one treatment and one control), a finite population of N experimental units is considered.
These N units receive one of the treatments through a randomized assignment mechanism, and
the observed outcomes from the two treatment groups are compared to draw inference on causal
estimands of interest. Such causal estimands can be defined in terms of potential outcomes, and
the framework for drawing inference in the setup described above is the well-known Neyman-Rubin
causal model (Sekhon 2008) or simply the Rubin causal model (Holland 1986). In particular, this
model posits that each unit i = 1, . . . , N has two fixed potential outcomes, Yi(1) and Yi(0), denot-
ing unit i’s outcome under treatment and control, respectively, and thus the only stochasticity in
a randomized experiment is units’ assignment to treatment groups.
The most common estimand in the causal inference literature is the finite-population average
treatment effect (ATE), defined as τ = 1N
∑N
i=1[Yi(1) − Yi(0)]. In a randomized experiment, ulti-
mately each unit can only be assigned to treatment or control—never both—and thus only Yi(1)
or Yi(0) is observed for each unit. As a result, τ must be estimated. The most common estimator
for τ is the mean-difference estimator, i.e., the mean difference in the observed treatment outcomes
and observed control outcomes. In this finite population setup where the potential outcomes are
assumed fixed, the mean-difference estimator is unbiased for τ , and its sampling variance was de-
rived by Neyman (1923). Using this estimator and sampling variance, a normal approximation can
be used to draw inference on τ . If additional covariates are available for each unit, covariate adjust-
ment can be performed to obtain more precise estimators for τ , such as through post-stratification
(Miratrix et al. 2013) or regression (Lin 2013).
However, in many practical situations, it may not be possible to observe a response for all N
units due to resource constraints. A natural way to address this limitation is to first randomly
sample n units from the population and then randomly assign the two treatments to the sampled
units. For example, this is a common procedure in political science and other social sciences, where
an experiment is conducted on a representative sample of some larger population, often through
a well-designed online survey (Mutz 2011; Coppock 2018; Miratrix et al. 2018). In this case, the
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(a) Design 1: Sampling in first stage and randomization
in second stage.
(b) Design 2: Randomization in first stage and sampling
in second stage.
Figure 1: Two sampling-based designs for estimation of ATE.
mean-difference estimator is still unbiased for the ATE, and its sampling variance has been studied
in works such as Imbens (2004) and Imbens and Rubin (2015, Chapter 6). Then, one can still
use the mean-difference estimator and its sampling variance to draw inference on τ via a normal
approximation. This scenario—where n units are sampled from a population of N units, and then
an experiment is conducted on these n sampled units—is shown in the left panel of Figure 1.
This article is motivated by a similar limitation as stated in the previous paragraph, but the
experimental design is different in the sense that the order of sampling and randomization is re-
versed. That is, first, each of the N units is assigned to one of the two treatments. Then, a subset
of units is sampled from the units exposed to each treatment group, and the response is measured
for each sampled unit. This experimental design scenario is shown in the right panel of Figure 1.
Such a strategy may be useful if sampling and measurement of response is more expensive and/or
complex compared to treatment assignment. Examples of experiments that involve this type of
design can be found in material science, biomedicine, and the social sciences. For example, in
an experiment conducted to assess the difference between two types of oxidation procedures with
respect to their impact on the dimension of nanotubes, scientists typically split a population (a
container of nanotubes) into two subpopulations (two smaller containers) and apply different oxida-
tion procedures to the two subpopulations (Remillard et al. 2016, 2017). However, since measuring
dimensions of nanotubes is an expensive and time-consuming process, a sample of oxidized nan-
otubes is taken from each subpopulation, and dimensions of the sampled nanotubes are measured.
A similar procedure is followed when conducting stem cell experiments (Chung et al. 2005; Doi
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et al. 2009).
The main contribution of this article is deriving the sampling properties of the mean-difference
estimator for the ATE under Design 2—we do this in Section 3 after setting up some notation
in Section 2. We will find that these sampling properties are identical to those under Design 1,
meaning that the ordering of the sampling and randomization stages is inconsequential for the
precision of the mean-difference estimator. This finding will also bring some clarifications about
inference of the ATE under Design 1, as we discuss in Section 3.1. In particular, the variance of
the mean-difference estimator under Design 1 is often characterized by asymptotic results where
N >> n or N =∞ (Imbens 2004; Imbens and Rubin 2015; Sekhon and Shem-Tov 2017), and our
work illuminates on the case where the population size and sample size are finite. Our work also
gives insight into other sampling-based randomized designs: For example, Design 2 is similar—but
not identical—to a cluster-randomized design (Campbell et al. 2007), where one cluster of size N1
is assigned to treatment group 1 and another cluster of size N0 is assigned to treatment group
0, and random samples are obtained within each cluster. Cluster-randomized designs are quite
common in education (Hedges and Hedberg 2007), medicine (Eldridge et al. 2004), and psychology
(Raudenbush 1997), and we discuss how Design 2 compares to cluster-randomized designs in Section
3.2. Then, in Section 4, we consider the case where baseline (pre-treatment) measurements of
the response can be obtained for a sample of experimental units, and we explore the extent to
which the mean-difference estimator can be improved under Design 2 by using such measurements.
Unfortunately, we will find that pre-treatment measurements are often unhelpful in improving the
precision of average treatment effect estimators under this design, unless a large number of pre-
treatment measurements that are highly associative with the post-treatment measurements can be
obtained. In Section 5, we confirm these results by conducting a simulation study based on a real
experiment in nanomaterials. In Section 6, we conclude.
2. Setup and Notations
Let the two treatments be denoted by 0 and 1, and for i = 1, . . . , N , let (Yi(0), Yi(1)) denote the
potential outcomes for unit i when exposed to treatments 0 and 1, respectively. The unit-level
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treatment effect is
τi = Yi(1)− Yi(0), i = 1, . . . , N,
and the finite-population ATE is
τ = N−1
N∑
i=1
τi = Y¯ (1)− Y¯ (0),
where Y¯ (1) = N−1
∑N
i=1 Yi(1) and Y¯ (0) = N
−1∑N
i=1 Yi(0) denote the average potential outcomes
for the treatment groups 1 and 0, respectively. We also denote the variances of the potential
outcomes for treatment group T ∈ {0, 1} as follows:
S2T = (N − 1)−1
N∑
i=1
(
Yi(T )− Y¯ (T )
)2
, (1)
and the covariance of potential outcomes for treatment groups 1 and 0 by
S10 = (N − 1)−1
N∑
i=1
(
Yi(1)− Y¯ (1)
) (
Yi(0)− Y¯ (0)
)
. (2)
Finally, the variance of the unit-level treatment effects is
S2τ = (N − 1)−1
N∑
i=1
(τi − τ)2 . (3)
As in Design 2 shown in the right panel of Figure 1, N1 and N0 units are assigned to treatments
1 and 0 respectively, where N1 and N0 are predetermined. From these two groups, n1 and n0 units
are sampled and their responses are observed. Let y¯(1) and y¯(0) denote the observed averages for
the treatment groups 1 and 0, respectively. Then, a natural estimator of τ is
τˆ = y¯(1)− y¯(0). (4)
We will examine the sampling properties of τˆ and compare them with those of a similar estimator
τ˜ obtained from Design 1 shown in Figure 1.
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3. Sampling properties of the estimator of the ATE
Because the potential outcomes are assumed fixed, the sampling properties of τˆ defined in (4) will
be determined by the random variables associated with the randomization and sampling stages. We
define two such variables now. For i = 1, . . . , N , let Ti denote a Bernoulli random variable indicating
the random level of treatment (0 or 1) that unit i receives. Recalling that the assignment mechanism
essentially involves a random partitioning of N units into two groups of predetermined sizes N0
and N1, the properties of the assignment vector (T1, . . . , TN ) are straightforward to establish and
can be found in standard texts (e.g., Imbens and Rubin 2015).
Next, define STii as an indicator random variable equaling 1 if the potential outcome Yi(Ti) is
randomly sampled among the units assigned to treatment level Ti ∈ {0, 1}. Importantly, note that
we know that S1i = 0 conditional on Ti = 0; i.e., the ith unit will not be sampled from treatment
group 1 if it was assigned to treatment group 0. As shown in the right panel of Figure 1, we assume
that samples of size n0 and n1 are sampled from treatment groups 0 and 1, respectively. Properties
of the STii are crucial in the derivation of sampling properties of τˆ , and are summarized in Lemma
1. The proofs are in Appendix A.
Lemma 1. The properties of the sampling indicators STii can be summarized as:
E
[
STii
]
= nTi/N, i = 1, . . . , N, (5)
Var
[
STii
]
= nTi/N{1− nTi/N}, i = 1, . . . , N, (6)
Cov
[
STii , S
Ti′
i′
]
=

−nTin1−Ti/N2, if i = i′, Ti 6= Ti′
−nTi{N−nTi}
N2(N−1) , if i 6= i′, Ti = Ti′ ,
nTin1−Ti
N2(N−1) , if i 6= i′, Ti 6= Ti′
(7)
Remark 1. To provide some intuition for (7), note that we expect the quantity Cov
[
STii , S
Ti′
i′
]
to
be negative if Ti = Ti′ , because if we know that unit i
′ is sampled in treatment group Ti, then unit
i is less likely to be sampled in the same group. Similarly, we expect the quantity Cov
[
S0i , S
1
i′
]
to
be positive, because if we know that unit i′ is sampled in treatment group 1, then unit i is more
likely to be sampled in treatment group 0.
We now represent the estimator τˆ in (4) in terms of the potential outcomes and the random
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variables Ti and S
Ti
i defined above. To do this, note that the average observed response in treatment
group T ∈ {0, 1} can be written as
y¯(T ) = (nT )
−1
N∑
i=1
STi Yi(T ), i = 1, . . . , N. (8)
By combining (4) and (8) and using Lemma 1, we now derive the sampling properties of the
estimator τˆ and summarize them in Theorem 1. The proof of Theorem 1 is in Appendix B.
Theorem 1. The estimator τˆ given by (4) satisfies the following properties:
1. τˆ is an unbiased estimator of the ATE τ .
2. The sampling variance of τˆ is given by
Var(τˆ) = S21/n1 + S
2
0/n0 − S2τ/N, (9)
where S20 and S
2
1 are given by (1) and S
2
τ is given by (3).
3.1. Comparison with two other sampling-based randomized designs
We now compare the sampling properties of τˆ as derived in Theorem 1 with the unbiased estimators
of τ obtained from two other designs: (i) a design where responses for all units are observed, that is,
no sampling is involved, and (ii) a design described as Design 1 in the left panel of Figure 1, where
n units are first sampled from N units in the population and subsequently exposed to treatments.
We denote the estimator of τ from (i) by ̂̂τ and that from (ii) by τ˜ . Both ̂̂τ and τ˜ are unbiased
estimators of τ . Neyman (1923) derived the following result on the sampling variance of ̂̂τ :
Var
(̂̂τ) = S21/N1 + S20/N0 − S2τ/N. (10)
As a result, we obtain the inequality Var
(̂̂τ) < Var (τˆ), reflecting the price one has to pay for
sampling from the finite population.
Meanwhile, to our knowledge, Imbens and Rubin (2015, Chapter 6, Appendix B) were the
first to derive the expression of the finite-population sampling variance of τ˜ , although others have
discussed the infinite-population case where N = ∞ (e.g., Imbens 2004). However, there was a
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slight error in the derivation in Imbens and Rubin (2015, Chapter 6, Appendix B): The covariance
between the sampling indicators was stated to be − ( nN )2, when really it is − n(N−n)N2(N−1) , as can be
seen by the i 6= i′, Ti = Ti′ case in Lemma 1 and other works on survey sampling (e.g., Lohr
2009, Page 53). As we show in Appendix C, by making this correction, and then following the
derivation of Imbens and Rubin (2015, Chapter 6, Appendix B), we have the following expression
of the sampling variance of τ˜ :
Var (τ˜) = S21/n1 + S
2
0/n0 − S2τ/N = Var (τˆ) (11)
Thus, the precision of the mean-difference estimator under Design 1 is identical to that under
Design 2; in other words, the order of the sampling and randomization stages is inconsequential in
terms of the precision of the mean-difference estimator. This finding also clarifies some discussions
in the causal inference literature that consider a super-population framework. When discussing
causal inference under a super-population framework, many works implicitly assume that N >> n
or N = ∞, and thus the third term in Var (τ˜), S2τ/N , is often ignored (Imbens (2004), Imbens
and Rubin (2015, Chapter 6), Ding et al. (2017), Sekhon and Shem-Tov (2017)). As we will see
in Section 3.3, this term is ignored in the estimation of Var(τˆ) or Var(τ˜), because the observed
data do not provide any information about S2τ , since none of the individual τi are ever observed.
However, the above derivation emphasizes that this term nonetheless exists in the true variance
of the mean-difference estimator under Design 1 and Design 2 when the super-population that is
sampled from is finite.
3.2. Comparison with cluster-randomized designs
As discussed in Section 1, Design 2 is similar but not identical to a cluster-randomized design, where
treatment is assigned among clusters of units but response is measured at the unit level. The most
important distinction between Design 2 and a cluster-randomized design is that, in Design 2, N0
and N1 (the number of units assigned to treatment groups 0 and 1, respectively) are fixed, and
in a cluster-randomized design, these quantities are stochastic. For example, consider a cluster-
randomized design with two clusters, where Cluster A has NA units and Cluster B has NB units,
and one cluster is randomly assigned to treatment group 0 and the other to treatment group 1.
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There is a 0.5 probability that N0 = NA and a 0.5 probability that N0 = NB, and N1 is analogously
stochastic.
This stochasticity causes many complications to inference—for example, the mean-difference
estimator is often biased in cluster-randomized designs, even when all units’ responses can be mea-
sured (Middleton 2008; Middleton and Aronow 2015). Consequently, there is not a straightforward
analog to our results that will hold for cluster-randomized designs; indeed, our results will not even
hold for the simple two-cluster example mentioned in the previous paragraph. Because we require
that N0 and N1 are fixed, our results will hold for cluster-randomized designs if the number of units
within each cluster is the same across clusters, but this is rarely the case. As discussed in Middle-
ton (2008) and Middleton and Aronow (2015), cluster sizes and the covariance between treatment
group sizes and treatment effects are important quantities for deriving inferential properties of ATE
estimators in cluster-randomized designs, and likely these quantities would be similarly important
in deriving analogous results when there is a sampling stage after treatment assignment at the
cluster level. We leave this for future work.
3.3. Estimation of sampling variance and approximate confidence intervals
Let
s20 =
1
n0 − 1
∑
i:S0i=1
{Yi(0)− y¯(0)}2 and s21 =
1
n1 − 1
∑
i:S1i=1
{Yi(1)− y¯(1)}2 (12)
denote the sample variances of observed responses for treatment groups 0 and 1, respectively. From
standard sampling theory (e.g., Lohr 2009, Pages 52-54), it follows that s20 and s
2
1 are unbiased
estimators of S20 and S
2
1 , respectively. Consequently,
vτˆ = s
2
0/n0 + s
2
1/n1 (13)
is a natural Neymanian-style estimator of Var(τˆ) and Var(τ˜), which, as seen in Section 3.1, has an
upward bias of S2τ/N unless strict additivity holds. This estimator—originating in Neyman (1923)—
is by far the most common estimator for the variance of the ATE in randomized experiments (Rubin
1990; Imbens 2004; Miratrix et al. 2013; Imbens and Rubin 2015; Ding et al. 2017), and thus it is
reassuring that it can be used for Var(τˆ) and Var(τ˜), i.e., it can be used under Design 1 or Design
9
2.
Estimator (13) can be used to obtain approximate confidence intervals for τ as
τˆ ± Φ−1(1− α/2)√vτˆ ,
where Φ−1(·) denotes the quantile function of a standard normal distribution. The asymptotic nor-
mality of τˆ is based on the finite population central limit theorem (Ha´jek 1960) and its application
in the context of randomized experiments by Li and Ding (2017).
4. Can the estimator be improved using pre-treatment measurements?
Now assume that the response can be measured for each experimental unit prior to application of the
treatments. Let X1, . . . , XN denote these measurements for the N units, which are fixed quantities
like the potential outcomes. The unit-level differences ∆1i = Yi(1) − Xi and ∆0i = Yi(0) − Xi
for i = 1, . . . , N are referred to as “gain scores” in the psychology (Rumrill and Bellini 2017)
and education (McGowen and Davis 2002) literature. While the unit-level gain scores or their
averages ∆1 = N
−1∑N
i=1 ∆1i and ∆0 = N
−1∑N
i=1 ∆0i are of interest in psychology and education
(Hake 1998), they are not referred to as causal estimands or causal effects (Rubin et al. 2004;
Imbens and Rubin 2015). However, it is easy to see that the unit-level and average treatment
effects can respectively be expressed as the unit-level and average differences of the gain scores,
i.e., τi = ∆1i −∆0i and τ = ∆1 −∆0. In spite of this connection, several experts in education and
psychology have recommended avoiding the use of gain scores when estimating treatment effects in
experiments and observational studies. Campbell and Erlebacher (1970) claimed, “gain scores are
in general . . . a treacherous quicksand,” and Cronbach and Furby (1970) recommended researchers
to “frame their questions in other ways.” Despite some recent interest on utilizing gain scores to
identify causal effects, there appears to be a general aversion in the causal inference community
towards the use of gain scores. Here we explore whether, in the current setup, a proper design
and analysis of the experiment using gain scores can potentially lead to more precise estimation of
treatment effects under certain assumptions.
In the setup of Design 2 in Figure 1, where measuring the pre-treatment response for each
unit is not feasible, it is often a common practice to measure the pre-treatment response for a
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random sample of size nx to estimate the average gain scores ∆1 and ∆0. Denoting the sampling
indicator by Z1, . . . , ZN , the estimators of ∆1 and ∆0 are y¯(1)− x¯ and y¯(0)− x¯, respectively, where
x¯ = n−1x
∑N
i=1 ZiXi. While the sampling properties of these estimators can be readily obtained,
they do not help in increasing the precision of the estimator of τˆ because the average pre-treatment
scores get canceled out in the difference of the gain score estimators. However, if samples of nx1
and nx0 pre-treatment observations are taken independently from the treatment groups 1 and 0
after assignment but before administration of the treatments, it is possible to obtain a different
estimator of the ATE. For i = 1, . . . , N , let ZTii denote the sampling indicator associated with the
random sampling of Xi among the units assigned to treatment Ti. Then
x¯(1) = (nx1)
−1
N∑
i=1
Z1iXi, and x¯(0) = (nx0)
−1
N∑
i=1
Z0iXi, (14)
are the observed sample averages of pre-treatment responses for the two treatment groups. Then
we can define the following estimator of the ATE:
τˆ∗ = ∆ˆ1 − ∆ˆ0 = {y¯(1)− x¯(1)} − {y¯(0)− x¯(0)} = τˆ − {x¯(1)− x¯(0)} , (15)
where x¯(1) and x¯(0) are given by (14). The sampling properties of τˆ∗ depend on the distribution
of ZTi and the joint distribution of STi and ZTi . These properties are summarized in the following
two lemmas.
Lemma 2. The properties of the indicators ZTii are exactly the same as those of S
Ti
i stated in
Lemma 1, just replacing nTi by nxTi and n1−Ti by nx1−Ti .
Lemma 3. For i, i′ = 1, . . . , N , the covariance between the indicators STii and Z
Ti′
i′ is given by:
Cov
[
STii , Z
Ti′
i′
]
=

nTinxTi
N1−Ti
NTiN
2 , if i = i
′, Ti = Ti′ ,
−nTinx1−Ti
N2
, if i = i′, Ti 6= Ti′ ,
−nTinxTiN1−Ti
NTiN
2(N−1) if i 6= i′, Ti = Ti′ ,
nTinx1−Ti
N2(N−1) if i 6= i′, Ti 6= Ti′ .
The proof for Lemma 3 is in Appendix D. Using Lemmas 2 and 3, we arrive at the following result:
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Theorem 2. The estimator τˆ∗ given by (15) satisfies the following properties:
1. τˆ∗ is an unbiased estimator of the ATE τ .
2. The sampling variance of τˆ∗ is given by
Var(τˆ∗) = Var(τˆ) +
(
1
nx1
+
1
nx0
)
S2x − 2
(
S1x
N1
+
S0x
N0
)
, (16)
where Var(τˆ) is given by (9) and
S2x = (N − 1)−1
N∑
i=1
(Xi − X¯)2, (17)
STx = (N − 1)−1
N∑
i=1
{
Yi(T )− Y¯ (T )
} {Xi − X¯}, T ∈ {0, 1}. (18)
The proof of Theorem 2 is in Appendix E.
Remark 2. From Theorem 2, it follows that τˆ∗ is a more efficient estimator than τˆ if and only if
2
(
S1x
N1
+
S0x
N0
)
>
(
1
nx1
+
1
nx0
)
S2x, which implies
2
(
S1
N1
r1x +
S0
N0
r0x
)
>
(
1
nx1
+
1
nx0
)
Sx,
(19)
where rTx =
STx
STSx
denotes the finite sample correlation coefficient between the potential outcomes
Y (T ) and pre-treatment measurements X. In order for condition (19) to be achieved, pre-treatment
measurements need to be highly predictive of the outcome, post-treatment outcomes need to be
substantially variable relative to the pre-treatment measurements, and pre-treatment measurements
need to be obtained for a large portion of the population. For example, consider the case where we
have a balanced design (i.e., N1 = N0 = N/2) and a balanced sample size (nx1 = nx0 = nx/2). In
this case, even if the pre-treatment measurements are perfectly correlated with the outcomes (i.e.,
r1x = r0x = 1), in order for (19) to be achieved, we need
nx
N (S1 + S0) > Sx, and usually
nx
N will
be small due to resource constraints. Similarly, if the pre-treatment measurements are moderately
correlated with the outcomes (e.g., r1x = r0x = 0.5) and all units’ pre-treatment measurements
are observed (i.e., nx = N), we still need
S1+S0
2 > Sx, i.e., the average standard deviation of
the post-treatment outcomes needs to be larger than the standard deviation of the pre-treatment
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measurements. Cases where r1x = r0x = 1 or nx = N are indeed quite extreme and unrealistic
conditions, and thus Theorem 2 in general gives credence to the skepticism many causal inference
experts have about using gain scores for estimation of treatment effects in the context of the
experimental design discussed here.
5. Simulation Study: Considering an Experiment in Nanomaterials
To assess how the findings from Theorems 1 and 2 are informative for real experiments, we now
conduct a simulation study based on a real experiment in nanomaterials (Remillard et al. 2017).
One purpose of this experiment was to assess how the dimensions of carbon nanotubes change as
they undergo different processing procedures. One such procedure is sonication, the primary pur-
pose of which is to disperse the nanotubes. However, sonication may also result in the undesirable
outcome of breaking the nanotubes, possibly causing changes to their length. The experiment con-
sidered two types of sonication—bath sonication and probe sonication—which are the treatments
in this application. Bath sonication is a more gentle procedure than probe sonication, so it was
hypothesized that bath sonication would not decrease the length of the carbon nanotubes as much
as probe sonication.
Because of practical constraints, this experiment was conducted using Design 2 in Figure 1.
Because the nanotubes are so small, it was infeasible to select individual nanotubes for treatment,
and instead, a container of nanotubes was evenly divided into two smaller containers, and each of
these containers underwent bath sonication or probe sonication. After sonication, nanotubes were
randomly selected and their length was measured after treatment. Furthermore, the length of a
random sample of nanotubes was measured before treatment. Primary interest was in the average
difference in log-length between bath sonication and probe sonication, i.e., the ATE; the log-length
was used due to skewness in the length distribution across carbon nanotubes.
In this paper, we have discussed two ATE estimators under Design 2: the mean-difference
estimator τˆ defined in (4), and the mean-difference estimator τˆ∗ defined in (15) that incorporates
pre-treatment information. In the real experiment conducted in Remillard et al. (2017), we could
only implement Design 2 once, and thus we could not observe the behavior of these estimators
across different randomizations and random samples of carbon nanotubes. In order to understand
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the behavior of these estimators across many implementations of Design 2, we will conduct a
simulation study mimicking this experiment.1
Consider the following implementation of Design 2 for this experiment: N = 1, 000 carbon
nanotubes will be randomly divided into treatment groups of sizes N1 = 500 (probe sonication)
and N0 = 500 (bath sonication). Random samples of sizes nx1 = 150 and nx0 = 150 will be
obtained before treatment, and random samples of sizes n1 = 150 and n0 = 150 will be obtained
after treatment; these were approximately the sample sizes that were used in the actual experiment.
The individual log-length of each carbon nanotube will be measured for these samples.
First, the population of pre-treatment measurements X as well as post-treatment measurements
Y(1) and Y(0) were generated using the following model:
 X
Y(0)
 ∼ N

µX
µY 0
 ,
 σ2X ρσXσY 0
ρσXσY 0 σ
2
Y 0


Y(1) = Y(0) + τ + στY(0)
(20)
As discussed in Remillard et al. (2017), normality was a reasonable distributional assumption to
place on the log-length of carbon nanotubes. The mean parameters (µX and µY 0), variance pa-
rameters (σ2X and σ
2
Y 0), and ATE parameter τ were set to the sample estimates observed in the
Remillard et al. (2017) experiment.2 The treatment effect heterogeneity parameter στ and associ-
ation parameter ρ could not be estimated in the experiment, because none of the (X,Y(1),Y(0))
could ever be jointly observed. In this simulation study, we set στ = 0.5 to induce strong treatment
effect heterogeneity (Ding et al. 2016) and consider various values for ρ.
After the population-level triplet {X,Y(1),Y(0)}i=1,...,N was generated once, the following
randomization and sampling procedures (i.e., Design 2) were repeated 10,000 times:
1. Each unit was randomly assigned to treatment group 1 or treatment group 0 with equal
probability, such that N1 = 500 and N0 = 500.
1In actuality, the Remillard et al. (2017) experiment considered several treatment factors, such as oxidation as
well as sonication, and it considered several types of carbon nanotubes. For ease of exposition, the simulation data
discussed here is based on the subset of the experiment that considered the carbon nanotube called “D15L1-5” in
Remillard et al. (2017). We chose this type of carbon nanotube because it was already oxidated, and thus only
sonication (i.e., one treatment factor) was used in the actual experiment for this type of carbon nanotube.
2Specifically, µX = −0.09, µY 0 = 0.09, σ2X = 0.32, σ2Y 0 = 0.51, and τ = −0.01, where the units are on the logµm
scale.
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2. Within each treatment group T ∈ {0, 1}, nxT = 150 units were randomly sampled and their
X recorded as an observed pre-treatment measurement.
3. Within each treatment group T ∈ {0, 1}, nT = 150 units were randomly sampled and their
Y(T ) recorded as an observed post-treatment measurement.
For each of the 10,000 replications, we recorded the ATE estimators τˆ defined in (4) and τˆ∗ defined
in (15). Recall that τˆ is the mean-difference estimator, and its properties under this design are
established by Theorem 1; meanwhile, τˆ∗ uses the pre-treatment measurements X to alter τˆ , and
its properties are established by Theorem 2.
First, let us consider one simulation setting to confirm the results in Theorems 1 and 2. Figure
2 shows the empirical distribution of τˆ and τˆ∗ after 10,000 replications of the above procedure
when the pre- and post-treatment measurements are moderately associated (ρ = 0.5). There are
two observations that can be made from Figure 2. First, the normal distributions for τˆ and τˆ∗
(constructed using Theorems 1 and 2, respectively) fit the empirical distributions of these estima-
tors; this confirms our theoretical results, including the comparison of these estimators given in
Remark 2. Second, under this setting, τˆ∗ is slightly more dispersed than τˆ , suggesting that using
the pre-treatment measurements in this case inflates the variance of the ATE estimator.
This second observation begs the question: In this scenario, when will using the pre-treatment
measurements improve estimation of the ATE? To address this question, we considered various
values for the association parameter ρ as well as the sample sizes nxT and nT for T ∈ {0, 1}. Figure
3 displays a heatmap of the empirical ratio Var(τˆ)Var(τˆ∗) for various values of ρ and the sample size.
Looking at the bottom row of this heatmap, we can see that for the sample of size of 150 that was
actually feasible for this experiment, even an association of ρ = 0.9 would not have led to τˆ∗ being
more precise than τˆ . For this experiment, the sample size would have had to significantly increase
while keeping the association moderately high in order for the pre-treatment measurements to be
useful in increasing the precision of the ATE estimator. This echoes the observation made at the
end of Section 4 that the use of gains scores is often not beneficial in improving ATE estimators.
In summary, the above simulation study confirms that Theorems 1 and 2 correctly establish
the behavior of the ATE estimators τˆ and τˆ∗ under Design 2. However, for these data that are
based on the experiment from Remillard et al. (2017), an infeasibly large number of pre-treatment
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Figure 2: 10,000 replications of τˆ (top) and τˆ∗ (bottom) when the pre- and post-treatment mea-
surements are moderately associated (ρ = 0.5) and there is strong treatment effect heterogeneity
(στ = 0.5). The lines denote normal densities, where the mean is the true treatment effect and the
variance is given by Theorem 1 for τˆ and Theorem 2 for τˆ∗.
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Figure 3: Heatmap of the empirical ratio Var(τˆ)Var(τˆ∗) across the 10,000 replications. We considered
values ρ ∈ {0, 0.1, . . . , 0.9} in (20) and sample sizes 150, 200, . . . , 450 for nx1, nx0, n1, and n0. Blue
shades suggest τˆ is more precise; red shades suggest τˆ∗ is more precise.
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measurements would need to be obtained in order for τˆ∗ to be more precise than τˆ , and these mea-
surements would need to be at least moderately associated with the post-treatment measurements.
As noted in Remark 2, this will also be the case for other experiments, unless the post-treatment
measurements are substantially more variable than the pre-treatment measurements, which was
not the case for the Remillard et al. (2017) experiment.
6. Discussion
Many causal inference works have focused on experimental settings where the outcomes for all units
in the experiment can be measured. In some settings, it is too expensive to conduct an experiment
on all units of interest, and instead an experiment is conducted on a random sample of units. Texts
such as Imbens and Rubin (2015) have shown that the inferential properties of common treatment
effect estimators in these settings can be established by first accounting for the stochasticity of
the sampling stage and then accounting for the stochasticity of the randomization stage. However,
inferential properties under the experimental design scenario where the ordering of the sampling and
randomization stages are reversed has not been established. Forms of this experimental design have
become increasingly common in the physical, medical, and social sciences, and so it is important
to understand statistical inference in this case.
We established the inferential properties of the mean-difference estimator under this experi-
mental design scenario, and we compared our findings to results for other experimental designs.
We found that the inferential properties of the mean-difference estimator under this experimental
design scenario are identical to those under the sample-first-randomize-second design, which is the
more common experimental design discussed in the literature. Thus, the ordering of the random-
ization and sampling stages is inconsequential for inference of average treatment effects. We also
assessed if pre-treatment measurements of units’ outcomes can be used to improve upon the mean-
difference estimator for this experimental design scenario. We found that this is only the case if (1)
the pre-treatment measurements are highly predictive of the outcome, (2) the post-treatment out-
comes are substantially variable relative to the pre-treatment measurements, and (3) pre-treatment
measurements are obtained for a large portion of the population. We also conducted a simulation
study based on an experiment in nanomaterials (Remillard et al. 2017) and found that these results
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hold for realistic applications.
A recent strand of causal inference literature has elucidated and leveraged the connection be-
tween experimental design and finite-population sampling to refine theory and methodology for
randomized experiments. This includes theory on design-based estimators for treatment effects
(Samii and Aronow 2012; Aronow and Middleton 2013), properties of covariate-adjustment in ran-
domized experiments (Freedman 2008; Lin 2013; Miratrix et al. 2013), and methods for estimating
treatment effects in complex experimental settings such as cluster-randomized experiments (Middle-
ton and Aronow 2015), experiments with interference (Aronow and Samii 2013), and experiments
with multiple treatments (Mukerjee et al. 2018). This work continues this trend of using experimen-
tal design and finite-population sampling techniques to characterize treatment effect estimation in
randomized experiments. As we discussed in Section 3.2, a promising line for future work is to es-
tablish analogous results for other types of experiments, such as cluster-randomized designs, where
there are multiple stages of stochasticity through sampling, randomization, and other mechanisms.
Appendices
A. Proof of Lemma 1
To prove (5), note that
E
[
STii
]
= Pr
[
STii = 1
]
= Pr[Unit i is assigned treatment Ti and is sampled] = NTi/N × nTi/NTi = nTi/N.
Next, we have that
Var
[
STii
]
= E
[(
STii
)2]− E2 [STii ] = nTi/N − {nTi/N}2 = nTi/N{1− nTi/N},
which proves (6).
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To prove (7), first we consider the case where i = i′ and Ti 6= Ti′ :
Cov
[
S0i , S
1
i
]
= E
[
S0i S
1
i
]− E [S0i ]E[S1i ]
= Pr [Unit i receives both treatments and is sampled]− E [S0i ]E[S1i ]
= 0− (n0/N)(n1/N) = −n0n1/N2.
Next, for the case where i 6= i′ and Ti = Ti′ , we have that:
E
[
STii S
Ti
i′
]
= Pr
[
Units i, i′ both receive treatment Ti and are sampled
]
= Pr
[
i, i′ are both sampled | both receive Ti
]
Pr [both receive Ti]
=
nTi(nTi − 1)
NTi(NTi − 1)
× NTi(NTi − 1)
N(N − 1) =
nTi(nTi − 1)
N(N − 1) .
Thus, it follows that,
Cov
[
STii , S
Ti
i′
]
= E
[
STii S
Ti
i′
]
− E
[
STii
]
E
[
STii′
]
=
nTi(nTi − 1)
N(N − 1) − (nTi/N)
2
= −nTi {N − nTi}
N2(N − 1) ,
after a little algebra.
Finally, for the case where i 6= i′ and Ti 6= Ti′ , we have that:
E
[
S0i S
1
i′
]
= Pr
[
i, i′ sampled|i receives 0 and i′ receives 1]Pr [i receives 0 and i′ receives 1]
= Pr[i sampled | i receives 0]Pr[i′ sampled | i′ receives 1]Pr [i receives 0 and i′ receives 1]
=
n0
N0
× n1
N1
× N0N1
N(N − 1) .
Consequently,
Cov
[
S0i , S
1
i′
]
= E
[
S0i S
1
i′
]− E [S0i ]E [S1i′]
=
n0
N0
× n1
N1
× N0N1
N(N − 1) −
n0
N
× n1
N
=
n0n1
N2(N − 1) .
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B. Proof of Theorem 1
To prove the first part, note that for T ∈ {0, 1}, y¯(T ) defined in (8) is an unbiased estimator of
Y¯ (T ) by (5). Consequently, from (4), τˆ is an unbiased estimator of τ . To prove the second part,
we need the following three lemmas:
Lemma 4. For T ∈ {0, 1},
S2T = N
−1

N∑
i=1
Y 2i (T )− (N − 1)−1
∑
i 6=i′
Yi(T )Yi′(T )
 .
Proof. By (1), for T ∈ {0, 1},
(N − 1)S2T =
N∑
i=1
{Yi(T )}2 −N−1
{
N∑
i=1
Yi(T )
}2
=
N∑
i=1
{Yi(T )}2 −N−1
 N∑
i=1
{Yi(T )}2 +
∑
i 6=i′
Yi(T )Yi′(T )

= N−1(N − 1)
N∑
i=1
{Yi(T )}2 −N−1
∑
i 6=i′
Yi(T )Yi′(T )
= N−1(N − 1)
 N∑
i=1
{Yi(T )}2 − (N − 1)−1
∑
i 6=i′
Yi(T )Yi′(T )
 .
Lemma 5. For T ∈ {0, 1},
Var [y¯(T )] =
N − nT
N
· S
2
T
nT
.
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Proof. By (8), for T ∈ {0, 1},
Var [y¯(T )] = Var
[
(nT )
−1
N∑
i=1
STi Yi(T )
]
= (nT )
−2
 N∑
i=1
{Yi(T )}2Var
[
STi
]
+
∑
i 6=i′
Yi(T )Yi′(T )Cov
[
STi , S
T
i′
]
= (nT )
−2
nT
N
(
1− nT
N
) N∑
i=1
{Yi(T )}2 − nT (N − nT )
N2(N − 1)
∑
i 6=i′
Yi(T )Yi′(T )
 , by Lemma 1
=
N − nT
nTN2
 N∑
i=1
{Yi(T )}2 − (N − 1)−1
∑
i 6=i′
Yi(T )Yi′(T )

=
N − nT
N
· S
2
T
nT
, by Lemma 4.
Lemma 6. The covariance between y¯(1) and y¯(0) is given by:
Cov [y¯(1), y¯(0)] = −S
2
1 + S
2
0 − S2τ
2N
.
Proof.
Cov [y¯(1), y¯(0)] = Cov
[
n−11
N∑
i=1
S1i Yi(1), n
−1
0
N∑
i=1
S0i Yi(0)
]
= (n0n1)
−1
 N∑
i=1
Yi(1)Yi(0)Cov
[
S1i , S
0
i
]
+
∑
i 6=i′
Yi(1)Yi′(0)Cov
[
S1i , S
0
i′
]
= (n0n1)
−1
−n0n1
N2
N∑
i=1
Yi(1)Yi(0) +
n0n1
N2(N − 1)
∑
i 6=i′
Yi(1)Yi′(0)
 , by Lemma 1
= − 1
N2(N − 1)
(N − 1) N∑
i=1
Yi(1)Yi(0)−
∑
i 6=i′
Yi(1)Yi′(0)

= − 1
N2(N − 1)
[
(N − 1)
N∑
i=1
Yi(1)Yi(0)−
{
N∑
i=1
Yi(1)
}{
N∑
i=1
Yi(0)
}
+
N∑
i=1
Yi(1)Yi(0)
]
= − 1
N(N − 1)
[
N∑
i=1
Yi(1)Yi(0)−NY¯ (1)Y¯ (0)
]
= −S10/N, by (2).
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The result follows from the identity S10 =
(
S21 + S
2
0 − S2τ
)
/2, which is straightforward to establish.
Straightforward applications of Lemma 5 and Lemma 6 lead to the proof of Theorem 1.
C. Deriving the Sampling Variance of τ˜
Let N denote the population size, n denote the sample size, and n1 and n0 denote the sizes of
treatment groups 1 and 0, respectively, all of which are fixed. Finally, let Si denote the sampling
indicator, where Si = 1 if unit i is sampled to be in the completely randomized experiment, and
Si = 0 otherwise. Note that—following results from Lemma 1 and from survey sampling (e.g., Lohr
2009, Page 53)—we have that E[Si] = n/N , Var(Si) = nN
(
1− nN
)
, and Cov(Si, Sj) = − n(N−n)N2(N−1)
for i 6= j. In Imbens and Rubin (2015, Chapter 6, Appendix B), it was incorrectly stated that
Cov(Si, Sj) = −
(
n
N
)2
, which is the main difference between their derivation and the derivation
presented here.
The variance of τ˜ can be derived by conditioning on the sampling indicators, S = (S1, . . . , SN ):
Var(τ˜) = E[Var(τ˜ |S)] + Var (E[τ˜ |S]) (21)
As discussed in Section 3.1, Neyman (1923) showed that Var(τ˜ |S) = s21n1 +
s20
n0
− s2τn , where s21 and
s20 are the sample variances defined in (12), and s
2
τ =
1
n−1
∑
i:Si=1
(τi − τS)2 is the variance of
the treatment effects in the sample, where τS = n
−1∑
i:Si=1
τi is the sample ATE. Meanwhile,
E[τ˜ |S] = τS (Imbens and Rubin 2015, Page 111). Finally, classical results on survey sampling (e.g.,
Lohr 2009, Page 36) have derived the variance of a sample mean under simple random sampling;
these results give us Var(τS) =
S2τ
n
(
1− nN
)
. Importantly, this last result is a consequence of the
fact that Cov(Si, Sj) = − n(N−n)N2(N−1) for i 6= j.
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Plugging these results back into (21), we have
Var(τ˜) = E
[
s21
n1
+
s20
n0
− s
2
τ
n
]
+ Var (τS) (22)
=
S21
n1
+
S20
n0
− S
2
τ
n
+ Var (τS) (where S
2
1 , S
2
0 , and S
2
τ are defined in Section 2) (23)
=
S21
n1
+
S20
n0
− S
2
τ
n
+
S2τ
n
(
1− n
N
)
(24)
=
S21
n1
+
S20
n0
− S
2
τ
N
= Var(τˆ)
(25)
as mentioned in Section 3.1, Equation (11).
D. Proof of Lemma 3
We will consider the four cases in Lemma 3. For the first case, when i = i′ and Ti = Ti′ ,
Cov(STii , Z
Ti
i ) = E[S
Ti
i Z
Ti
i ]− E[STii ]E[ZTii ]
= Pr(STii = 1, Z
Ti
i = 1)−
nTinxTi
N2
= Pr(STii = 1|ZTii = 1)Pr(ZTii = 1)−
nTinxTi
N2
= Pr(STii = 1|unit i is assigned to Ti)Pr(ZTii = 1)−
nTinxTi
N2
=
nTi
NTi
nxTi
N
− nTinxTi
N2
=
N1−TinTinxTi
N2NTi
, after some algebra.
(26)
Now for the second case. When i = i′ and Ti 6= Ti′ , Pr(STii = 1, ZTi′i′ = 1) = 0. Plugging this
into the same procedure as (26), we have that Cov(STii , Z
Ti′
i′ ) = −
nTinxTi′
N2
.
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Now for the third case. When i 6= i′ and Ti = Ti′ ,
Cov(STii , Z
Ti
i′ ) = E[S
Ti
i Z
Ti
i′ ]− E[STii ]E[ZTii′ ]
= Pr(STii = 1, Z
Ti
i′ = 1)−
nTinxTi
N2
= Pr(STii = 1|ZTii′ = 1)Pr(ZTii′ = 1)−
nTinxTi
N2
= Pr(STii = 1|unit i′ is assigned to Ti)Pr(ZTii′ = 1)−
nTinxTi
N2
=
nTi − 1
NTi − 1
Pr(ZTii′ = 1)−
nTinxTi
N2
=
nTi − 1
NTi − 1
nxTi
N
− nTinxTi
N2
= − N1−TinTinxTi
N2(N − 1)NTi
, after some algebra.
(27)
Now for the fourth case. When i 6= i′ and Ti 6= Ti′ ,
Cov(STii , Z
Ti′
i′ ) = E[S
Ti
i Z
Ti′
i′ ]− E[STii ]E[Z
Ti′
i′ ]
= Pr(STii = 1, Z
Ti′
i′ = 1)−
nTinx1−Ti
N2
= Pr(STii = 1|ZTi′i′ = 1)Pr(Z
Ti′
i′ = 1)−
nTinx1−Ti
N2
=
nTi
NTi
NTi
N − 1Pr(Z
Ti′
i′ = 1)−
nTinx1−Ti
N2
=
nTi
NTi
NTi
N − 1
nx1−Ti
N
− nTinx1−Ti
N2
=
nTinx1−Ti
N2(N − 1) , after some algebra.
(28)
E. Proof of Theorem 2
To prove this theorem, we first state and prove the following two lemmas:
Lemma 7. For T, T ′ ∈ {0, 1}, Var[x¯(T )] = (1− nxT /N)S2x/nxT and Cov[x¯(T ), x¯(T ′)] = −S2x/N .
Proof. The proof follows from arguments similar to those in the proofs of Lemma 5 and Lemma 6,
utilizing the properties of indicators (ZTii , S
Ti
i ) stated in Lemma 2 and 3.
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Lemma 8. For T, T ′ ∈ {0, 1},
Cov
[
y¯(T ), x¯(T ′)
]
=

N1−T
NT
STx
N if T = T
′
−STxN if T 6= T ′
(29)
where STx is given by (18).
Proof. For the first case, when T = T ′,
Cov [y¯(T ), x¯(T )] = Cov
[
n−1T
N∑
i=1
STi Yi(T ), n
−1
xT
N∑
i=1
ZTi Xi
]
= (nTnxT )
−1
 N∑
i=1
Yi(T )XiCov
(
STi , Z
T
i
)
+
∑
i 6=i′
Yi(T )Xi′Cov
(
STi , Z
T
i′
)
Substituting expressions for Cov
(
STi , Z
T
i
)
and Cov
(
STi , Z
T
i′
)
from Lemma 3 and after some alge-
braic simplifications similar to those in Lemma 6, it follows that
Cov [y¯(T ), x¯(T )] =
1
N2NT (N − 1)
[
NN1−T
N∑
i=1
Yi(T )Xi −N1−T
{
N∑
i=1
Yi(T )
}{
N∑
i=1
Xi
}]
=
N1−T
NT
STx
N
Next, for the second case where T 6= T ′,
Cov
[
y¯(T ), x¯(T ′)
]
= Cov
[
n−1T
N∑
i=1
STi Yi(T ), n
−1
x1−T
N∑
i=1
ZT
′
i Xi
]
= (nTnx1−T )
−1
 N∑
i=1
Yi(T )XiCov
(
STi , Z
T ′
i
)
+
∑
i 6=i′
Yi(T )Xi′Cov
(
STi , Z
T ′
i′
)
Substituting expressions for Cov
(
STi , Z
T ′
i
)
and Cov
(
STi , Z
T ′
i′
)
from Lemma 3 and after some al-
gebraic simplifications similar to those in Lemma 6, the above expression simplifies to −STx/N .
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Now to prove Theorem 2, we write
Var(τˆ∗) = Var [τˆ ] + Var [x¯(1)− x¯(0)]− 2Cov [τˆ , x¯(1)− x¯(0)] . (30)
The second term equals Var[x¯(1)] + Var[x¯(0)] − 2Cov[x¯(1), x¯(0)]. Substituting the expressions for
Var[x¯(1)], Var[x¯(0)] and Cov[x¯(1), x¯(0)] from Lemma 7 and after some simplification, we have that
Var [x¯(1)− x¯(0)] = (n−1x1 + n−1x0 )S2x. (31)
The expression Cov [τˆ , x¯(1)− x¯(0)] in the third term can be written as:
Cov [y¯(1)− y¯(0), x¯(1)− x¯(0)]
= Cov [y¯(1), x¯(1)]− Cov [y¯(1), x¯(0)]− Cov [y¯(0), x¯(1)] + Cov [y¯(0), x¯(0)]
=
N0
N1
S1x
N
+
S1x
N
+
S0x
N
+
N1
N0
S0x
N
=
S1x
N1
+
S0x
N0
, (32)
where the last step follows by substitution of the relevant expressions from Lemma 8.
Finally, the result follows by substituting (31) and (32) in (30).
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